Esperion Therapeutics Inc (ESPR)
Deferred Revenue
$43.53M
Quarterly · Period ending: · USD
ESPR Deferred Revenue
Latest reported$34.48Mperiod ending
Latest reported$34.48Mperiod ending
ESPR FY Deferred Revenue ($0.00 → $34.48M)
Annual deferred revenue
High-resolution chart · PNG
ESPR deferred revenue history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Deferred Revenue (USD) |
|---|---|
| 34,477,000 | |
| 8,518,000 | |
| 25,402,000 | |
| 3,507,000 | |
| 5,683,000 | |
| 1,662,000 | |
| 2,152,000 | |
| 0 | |
| 38,000 | |
| 40,000 | |
| 37,000 | |
| 107,000 | |
| 0 | |
| 1,190,692 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |